Target intelligence / Profile preview

Microbial biofilm extracellular polymeric substance matrix (EPS matrix) (EPS matrix)

Target
EPS matrix
Molecular classification
Other
01

Overview

The microbial biofilm matrix, primarily composed of extracellular polymeric substances (EPS), is a dynamic and complex scaffold that encases microbial communities. This matrix consists of polysaccharides, proteins, lipids, and extracellular DNA (eDNA), which together provide structural integrity and protection against environmental stressors, including host immune defenses and antimicrobial agents [1]. Associated cell surface properties, such as adhesins, pili, and fimbriae, are crucial for the initial attachment of cells to surfaces and for maintaining the cohesive strength of the biofilm [2]. In clinical contexts, the matrix acts as a physical and chemical barrier that contributes significantly to the high level of antibiotic tolerance observed in chronic infections, such as those found in cystic fibrosis or on indwelling medical devices [3]. Therapeutic targeting of the matrix involves the use of enzymes like DNases or glycoside hydrolases to degrade its components, or chelating agents to disrupt the ionic cross-linking that stabilizes the structure [4]. By breaking down this protective shield, these treatments aim to restore the susceptibility of the embedded pathogens to conventional antibiotics and host clearance mechanisms [5]. Sources: [1] Flemming, H. C., & Wingender, J. (2010). Nature Reviews Microbiology; [2] Berne, C., et al. (2018). Nature Reviews Microbiology; [3] Ciofu, O., et al. (2022). Nature Reviews Microbiology; [4] Tetz, G. V., et al. (2009). Antimicrobial Agents and Chemotherapy; [5] Lu, T. K., & Collins, J. J. (2007). PNAS.

Other names
Biofilm matrixExtracellular polymeric substancesEPS matrixBiofilm scaffoldMicrobial biofilm matrix and associated cell surface properties
02

Mechanism of action

Enzymatic degradation of extracellular DNA and polysaccharides, chelation of divalent cations to destabilize the matrix, and reduction of disulfide bonds in matrix proteins.

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Systemic dissemination of bacteriaInflammatory response to released matrix componentsRisk of septicemia
06

Interacting drugs

Dornase alfa

4 more in the full profile.

07

Biomarkers

Extracellular DNA (eDNA)AlginatePel polysaccharidePsl polysaccharideCyclic-di-GMP

Beyond the preview

Go deeper on Microbial biofilm extracellular polymeric substance matrix (EPS matrix) (EPS matrix).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial biofilm extracellular polymeric substance matrix (EPS matrix) (EPS matrix).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call